Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05167682
Other study ID # V02-20012021
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 1, 2021
Est. completion date March 31, 2024

Study information

Verified date June 2024
Source University of Cologne
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The PAPRIKA project is a feasibility study with duration of 10 months. The aim of the study is to recruit 25 patients over the age of 65 who will undergo tumor-related esophagectomy and will follow a prehabilitation program to prevent postoperative complications and improve patient-centric complications and patient-centered outcomes. After determination of the oncologic treatment plan in the tumor board and functional assessment, patient will undergo an interdisciplinary assessment , which will be performed by the PAPRIKA team consisting of physiotherapists, internists/geriatricians, speech and occupational therapists, nutritionists and surgeons. On the basis of this interdisciplinary assessment an individualized catalog of procedures will be created. Patient have to follow to this catalog of procedures until surgery. Procedures catalog contains behavioral changes, physical training, nutritional counseling, conditioning of pulmonary function and optimization of drug treatment of underlying diseases. The individual treatments will be weekly reevaluated and if necessary the procedures will be adjusted by treatment teams. The prehabilitation procedures will be communicated with the patient via a smartphone app, which is specially developed for the prehabilitation program. The implementation will be documented. The primary aim of this study is to evaluate the compliance of the patients regarding to the prescribed procedures and the use of the smartphone app (feasibility). As secondary aim postoperative outcome will be compared with the results of a historical cohort for quality control.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date March 31, 2024
Est. primary completion date March 20, 2024
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria - Patients ,undergoing transthoracic esophagectomy (Ivor Lewis), in = 4 weeks - Age >65 years - American Society of Anaesthesiologists - Score: 2-3 - Ability to give informed consent - Written informed consent Exclusion Criteria: - Planned operation in less than 4 weeks after enrollment - Urgent surgery indication - Patients with good to excellent general and nutritional condition (0 points in the pre-screening of the modified NRS OR 1 point in the pre-screening and <2 points in the main screening). - Patients deemed by the PAPRIKA team to be physically or mentally incapable of completing the exercise program.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Prehabilitation program
Patient will be asked to follow to catalog of procedures till surgery. Procedures catalog contains behavioral changes, physical training, nutritional counseling, conditioning of pulmonary function and optimization of drug of underlying diseases.

Locations

Country Name City State
Germany University Hospital of Cologne Cologne

Sponsors (4)

Lead Sponsor Collaborator
University of Cologne Centre for Prevention and Rehabilitation, University Hospital Cologne, Department of Endocrinology, Diabetology and Preventive Medicine, Department of General, Visceral, Tumor and Transplant Surgery, University Hospital Of Cologne

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Compliance of patients as feasibility of prehabilitation program Percentage of patients will be assessed, who have successfully completed all study visits and have installed and used the smart phone app at least once 90 days after surgery
Secondary Postoperative outcome Postoperative outcome will be measured with occurrence of postoperative and patient-centric complications. 90 days after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT02263664 - Observational Study of Sublingual Microcirculatory Blood Flow Characteristics in Patients Undergoing Transthoracic Esophagectomy N/A